[{"data": {"name": "Population pharmacokinetics and pharmacodynamics of BYL719, a phosphoinositide 3-kinase antagonist, in adult patients with advanced solid malignancies", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Stefan S. De Buck", "@type": "Person"}, {"name": "Annamaria Jakab", "@type": "Person"}, {"name": "Markus Boehm", "@type": "Person"}, {"name": "Douglas Bootle", "@type": "Person"}, {"name": "Dejan Juric", "@type": "Person"}, {"name": "Cornelia Quadt", "@type": "Person"}, {"name": "Timothy K. Goggin", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc4243905?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Wiley-Blackwell", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1111/bcp.12378", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCfiXRzir3YNC-CT15UsqAdkFAY-CDVXqpiLL612N-CR8WErBZHhqEN", "propertyID": "ISCC"}], "datePublished": "2014-08-21"}, "schema": "schema.org", "mediatype": "application/ld+json"}]